Home › Funds › DUPONT CAPITAL MANAGEMENT CORP › SLXNW

DUPONT CAPITAL MANAGEMENT CORP position in SLXNW

SILEXION THERAPEUTICS CORP · Health Care

DUPONT CAPITAL MANAGEMENT CORP reported holding 32,500 shares of SLXNW (SILEXION THERAPEUTICS CORP) in its Q3 2026 13F filing — a position valued at US$306K, representing 0.02% of its reported portfolio and ranking #28 among its reported holdings. DUPONT CAPITAL MANAGEMENT CORP has disclosed SLXNW holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)32.50K sh
Reported value held$306.00K
Portfolio Weight0.02%
First reportedQ3 2024
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How DUPONT CAPITAL MANAGEMENT CORP's SLXNW position evolved

DUPONT CAPITAL MANAGEMENT CORP first disclosed a stake in SLXNW in Q3 2024 at 32,500 shares (US$1K). The position peaked in Q2 2026 at 32,500 shares, worth US$988K. Across 9 filings, DUPONT CAPITAL MANAGEMENT CORP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 32,500 shares valued at US$306K.

Quarter by quarter

QuarterSharesValueChange
Q3 2024 32.50K $975 New
Q4 2024 32.50K $1.10K Hold
Q1 2025 32.50K $2.28K Hold
Q2 2025 32.50K $1.24K Hold
Q3 2025 32.50K $1.14K Hold
Q4 2025 32.50K $884 Hold
Q1 2026 32.50K $406 Hold
Q2 2026 32.50K $988.00K Hold
Q3 2026 32.50K $306.00K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SLXNW and 13F data

SLXNW (SILEXION THERAPEUTICS CORP) is a Health Care company. 20 other funds we track also report a position in SLXNW — the largest reported positions include SECURITY BENEFIT LIFE INSURANCE CO /KS/ (US$1K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SLXNW

All SLXNW fund holders →

FAQ

How long has DUPONT CAPITAL MANAGEMENT CORP held SLXNW?

DUPONT CAPITAL MANAGEMENT CORP has disclosed SLXNW holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is DUPONT CAPITAL MANAGEMENT CORP's current position in SLXNW?

As of Q3 2026, DUPONT CAPITAL MANAGEMENT CORP holds 32.50K shares of SLXNW (SILEXION THERAPEUTICS CORP), valued at $306.00K, representing 0.02% of its reported portfolio and ranking #28.

Has DUPONT CAPITAL MANAGEMENT CORP been buying or selling SLXNW?

In the latest 13F filing (Q3 2026), DUPONT CAPITAL MANAGEMENT CORP held unchanged its position in SLXNW. The position peaked in Q2 2026 at 32.50K shares.

Which other funds hold SLXNW?

Other major institutional holders of SLXNW include SECURITY BENEFIT LIFE INSURANCE CO /KS/, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.